Skip to Content

Cystagon (cysteamine) Disease Interactions

There are 2 disease interactions with Cystagon (cysteamine):

Major

Cysteamine (Includes Cystagon) ↔ alcoholism

Severe Potential Hazard, Moderate plausibility. Applies to: Alcoholism

The use of alcohol may increase the rate of cysteamine release and/or adversely alter the pharmacokinetic properties, as well as the effectiveness and safety. It is recommended to avoid the consumption of alcoholic beverages during treatment with cysteamine.

Moderate

Cysteamine (Includes Cystagon) ↔ liver disease

Moderate Potential Hazard, Moderate plausibility. Applies to: Liver Disease

The use of cysteamine has been associated with development of hepatic coma in patients with overt hepatic damage. Therapy with cysteamine should be administered cautiously in patients with liver disease.

References

  1. "Product Information. Cystagon (cysteamine)." Mylan Pharmaceuticals, Morgantown, WV.

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide